Management and Preparedness for Infusion and Hypersensitivity Reactions-Reference-Cited by-同舟云学术

Management and Preparedness for Infusion and Hypersensitivity Reactions

Published:2007-05-01 Issue:5 Volume:12 Page:601-609
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Lenz Heinz-Josef¹

Affiliation:

1. University of Southern California, Los Angeles, California, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: Discuss the physiology of the different clinical hypersensitivity and infusion reactions to monoclonal antibodies and chemotherapy.Select appropriate prevention and treatment strategies for hypersensitivity reactions.Describe the differences between acquired and acute hypersensitivity reactions. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Funder

Bristol-Myers Squibb

ImClone Systems, Inc.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-5-601

Reference41 articles.

1. Prevention and management of antineoplastic-induced hypersensitivity reactions;Zanotti;Drug Saf,2001

2. Hypersensitivity reactions related to oxaliplatin (OHP);Brandi;Br J Cancer,2003